Alternatives
Alternatives to Epclusa 400 mg/100 mg tablet
1 other presentations of Sofosbuvir and Velpatasvir 400 mg/100 mg tablet
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Sofosbuvir and Velpatasvir), strength (400 mg/100 mg) and dosage form (tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Epclusa 400 mg/100 mg tabletThis pageOral | Gilead Sciences | US FDA | 28 tablets | Store below 30 °C (86 ºF). | On request | — | Available on request |
| Sofosbuvir and Velpatasvir 400 mg/100 mg tabletOral | — | US FDA | 2 blister pack | Store below 30 °C (86 ºF). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Epclusa 400 mg/100 mg tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.